pharm hw 76-100 Flashcards
Patients with \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ are at significant risk for toxic effects of medications or metabolic waste products in the body. Choose one answer. A. renal failure B. diabetes mellitus C. stomach cancer D. heart failure
a
Patients with primary pulmonary hypertension may experience acute decompensation if they are given a: Choose one answer. A. salicylate. B. vasopressor. C. diuretic. D. bronchodilator.
b
Phenothiazine medications exert their antiemetic properties by:
Choose one answer.
A. promoting the secretion of hormones in the brain that depress the function of the medulla oblongata.
B. antagonizing dopaminergic receptor sites in the brain, which suppresses the function of the hypothalamus.
C. blocking histamine-2 receptors, which inhibits gastric acid production and slows peristalsis.
D. activating dopaminergic receptors in the brain and releasing hormones that depress the reticular activating system.
d
Physiologic drug antagonism occurs when:
Choose one answer.
A. the action of one medication increases or decreases the ability of another medication to be absorbed by the body.
B. two medications, each producing opposite effects, are present simultaneously, resulting in minimal or no clinical changes.
C. the effect of one medication is enhanced by the presence of another medication, which does not have the ability to produce the same effect.
D. two medications, each producing identical effects, are present simultaneously, resulting in an enhanced physiologic response.
b
Repolarization and myocardial contraction are occurring through phases: Choose one answer. A. 0 and 1. B. 1 and 2. C. 2 and 3. D. 3 and 4.
c
Stimulation of alpha-1 receptors results in: Choose one answer. A. insulin secretion. B. vasoconstriction. C. arterial dilation. D. glucagon secretion.
b
Stimulation of alpha-2 receptors:
Choose one answer.
A. constricts the vascular smooth muscle.
B. suppresses the release of norepinephrine.
C. causes profound systemic hypertension.
D. increases the release of norepinephrine.
b
Stimulation of beta-1 adrenergic receptors would produce all of the following effects, EXCEPT:
Choose one answer.
A. an increase in heart rate.
B. increased renin secretion.
C. increased cardiac electrical conduction.
D. decreased myocardial contractility.
d
Stimulation of beta-2 receptors will cause:
Choose one answer.
A. bronchoconstriction.
B. the airway diameter to dilate.
C. vasoconstriction and hypertension.
D. a decreased release of norepinephrine.
b
Succinylcholine should not be used in patients with: Choose one answer. A. a closed head injury. B. known hyperkalemia. C. a rapid heart rate. D. suspected hypokalemia.
b
The ability of a medication to initiate or alter cell activity in a therapeutic or desired manner is referred to as: Choose one answer. A. potency. B. efficacy. C. affinity. D. the threshold level.
b
The Comprehensive Drug Abuse Prevention and Control Act of 1970:
Choose one answer.
A. regulated the import, manufacture, prescription, and sale of several nonnarcotic medications and cocaine, opium, and their derivatives.
B. was aimed at protecting the public from mislabeled, poisonous, or otherwise harmful food, medications, and alcoholic beverages.
C. increased the penalties for violation of the Harrison Narcotic Act, made the possession of heroin illegal, and outlawed the acquisition and transportation of marijuana.
D. was a legislative act dealing with narcotic and nonnarcotic medications that have a potential for abuse, and developed a drug classification system according to the abuse potential of the medications.
d
The generic name of a medication:
Choose one answer.
A. does not require FDA approval.
B. is proposed by the manufacturer.
C. is proprietary and cannot be reproduced.
D. contains a string of letters and numbers.
b
The ideal body weight for a woman who is 5 ft 5 in tall is: Choose one answer. A. 52 kg. B. 57 kg. C. 62 kg. D. 66 kg.
b
The paramedic can avoid technical errors in medication administration by:
Choose one answer.
A. using a current, reliable medication reference source before administering the medication.
B. having a partner confirm the volume in a syringe or a weight-based medication calculation.
C. contacting medical control and confirming that the proposed dose is appropriate for the patient.
D. evaluating a patient for medication allergies or hypersensitivity before administering the medication.
b